Powering Progress | Ep. 3 – The Fuel Behind the Future: How AI Gets Its Power
Powering Progress | Ep. 2 – Financing at Scale: Structured Capital for AI and Data Center Portfolios
Powering Progress | Ep. 1 – Texas at the Edge of the Grid: Powering the Age of AI
Episode 412: New Cuba Sanctioons Expansion and Compliance
AI State Regulatory Frontiers: Inside the New Wave of State AI Laws — Regulatory Oversight Podcast
AI State Regulatory Frontiers: Inside the New Wave of State AI Laws
Episode 411 -- Third-Party AI Risk and Vendor Due Diligence
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
AI State Regulatory Frontiers: How Existing Laws Regulate AI — Regulatory Oversight Podcast
At the Intersection of Biotech and AI with Janice Vatland
The Presumption of Innocence Podcast: Episode 83 - Section 230 at 30: Can the Law That Built the Internet Survive?
Podcast - Inside Telehealth's Growth, Regulation and Access
Podcast — The Growth Rocketship: Using AI and Human Expertise to Build Tomorrow’s Leading Brands With A-Frame
Exploring Legal Trends in Social Media Liability
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo-Immuno Tech & MUSC
Podcast — The Growth Rocketship: Navigating the Institutional Evolution of the Blockchain World With ParaFi
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
Podcast - Resilience, Not Perfection: Cybersecurity Enterprises in the Age of AI
Spring has arrived, and privacy laws are sprouting alongside the crocuses. Oklahoma and Alabama became the 20th and 21st states to enact comprehensive consumer privacy laws in March and April. ...more
Technology has significantly expanded the reach, permanence, and amplification of student harm. As students navigate relationships in digital spaces, emerging concerns such as online threats, image-based sexual abuse (IBSA),...more
Another Food and Drug Law Institute (FDLI) Annual Conference is in the books, and the Food and Drug Administration’s (FDA) messaging at the 2026 edition blended big-picture aspirations with clear near-term change. Right from...more
On March 19, 2026, Sen. Elizabeth Warren and Sen. Richard Blumenthal sent a letter to Jensen Huang, Chief Executive Officer of NVIDIA, suggesting that NVIDIA may have engaged in a transaction for avoidance in violation of the...more
The Atlanta Bar Association Litigation Section hosted a May 8, 2026, panel discussion examining how artificial intelligence is beginning to challenge traditional assumptions about authenticity, reliability, admissibility, and...more
To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more
Colorado lawmakers are moving to repeal the state’s first-in-the-nation AI antidiscrimination law and replace the mandatory bias audit and risk impact assessment requirements with a streamlined transparency-and-notice...more
On April 24, 2024, the Department of Justice (DOJ) published a final rule to adopt the Web Content Accessibility Guidelines, version 2.1 Level AA (WCAG 2.1) as the compliance standard for web and mobile app accessibility for...more
On April 14, 2026, the United States Food and Drug Administration (“FDA”) issued a draft guidance for sponsors seeking approval of human gene-editing therapy products involving gene-editing technologies. ...more
Baseball is often referred to as “America’s pastime,” but for some baseball fans, it may double as worktime. While employers have long known that workers occasionally play hooky to attend afternoon ballgames, viral videos and...more
Rituximab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more
The OECD Council's Recommendation on Artificial Intelligence (the "Recommendation") adopted by 49 adherents as of April 2026 (the "Adherents"), contains: The OECD's AI Principles (the "Principles") , which were the first...more
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as...more
On May 7, 2026, Canvas, a popular cloud-based education platform used by over 8,000 K-12 schools and higher education institutions across the United States, was shut down by a cyberattack. Universities, colleges and school...more
On May 4, 2026, the FDA approved Lannett Company, Inc. (“Lannett”), Lanexa Biologics LLC (“Lanexa”), and Sunshine Lake Pharma’s LANGLARA (insulin glargine-aldy) as an interchangeable biosimilar to Sanofi’s LANTUS (insulin...more
As covered in our prior alert, the USPTO’s new pre-order paper procedure allows a patent owner to file a 30-page paper within 30 days after being served with an ex parte reexamination (EPR) request filed with the Central...more
The Federal Trade Commission (“FTC”), in its ongoing efforts to refine its approach to data privacy enforcement, convened a workshop earlier this year titled “Measuring Injuries and Benefits in the Data-Driven Economy,” a...more
Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Cassidy convened two healthcare hearings in Louisiana in advance of his Senate primary on May 16, 2026. He was the only committee member in attendance....more
Recent developments suggest that major health care and life sciences organizations are expanding their use of AI beyond trial initiatives and targeted applications, while federal and state policymakers struggle to develop...more
State legislatures continue to move aggressively on artificial intelligence regulation in 2026, with Colorado, Connecticut, and California each advancing significant and distinct AI governance frameworks....more
Recently, I blogged about how you should remain vigilant when using AI to help draft disclosure – and I parsed an example to scare you into not over relying on AI....more
News Briefs - Administration Exempts Foreign Doctors From Travel Ban - Foreign doctors will be able to receive visas allowing them to practice in the United States, after the Trump administration quietly changed a policy to...more
Discover how an Alternative Legal Services Provider (ALSP) Platform transforms delivery of legal services through artificial intelligence (AI), process optimization, and outcome-driven delivery models....more
The U.S. Environmental Protection Agency (EPA) has provided new insight into how it reviews mixed metal oxides (MMOs), including cathode active materials (CAMs) and modified or doped CAMs, under the Toxic Substances Control...more
This is the first installment of a new insurance claims-focused series within Defending the Algorithm™, written and edited by Pittsburgh, Pennsylvania Insurance and Commercial Litigation Attorney Christopher M. Jacobs, Esq.,...more